In vivo selection of Pseudomonas aeruginosa with decreased susceptibilities to fluoroquinolones during fluoroquinolone treatment of urinary tract infection

Urology

Volumn 58, Issue 1, 2001, Pages 125-128

  Nakano, Masahiro ^a   Yasuda, Mitsuru ^a   Yokoi, Shigeaki ^a   Takahashi, Yoshihito ^a   Ishihara, Satoshi ^a   Deguchi, Takashi ^a,b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFPIROME; CEFSULODIN; CEFTAZIDIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

AGED; ALCALIGENES FAECALIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; ENTEROCOCCUS FAECALIS; GENE MUTATION; GENETIC SELECTION; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT FAILURE; URINARY TRACT INFECTION;

AGED; ANTI-INFECTIVE AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA; SPECIES SPECIFICITY; TREATMENT FAILURE; URINARY TRACT INFECTIONS;

EID: 0034940584     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01110-4     Document Type: Article

References (20)

1. Development of resistance during antimicrobial therapy; a review of antibiotic classes and patient characteristics in 173 studies
2. Dose-finding study of gatifloxacin in complicated urinary tract infections
3. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients
4. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates
5. Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV
6. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa
7. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon
8. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug resistance strains of Pseudomonas aeruginosa
9. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa
10. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
11. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa
12. Mechanisms of quinolone resistance
13. Prevention of drug access to bacterial targets; permeability barriers and active efflux
14. Characterization of the MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa
15. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa
16. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections
17. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy
18. Development of multiple-antibiotic-resistant (MAR) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones